v3.20.1

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash	$ 458,845	$ 1,129,702
Accounts receivable, less allowance for doubtful accounts of $158,600 at March 31, 2020 and 179,600 at December 31, 2019	121,331	72,227
Inventories	874,710	891,587
Other current assets	317,288	334,493
Total current assets	1,772,174	2,428,009
LEASEHOLD IMPROVEMENTS AND EQUIPMENT, NET	3,466,419	3,676,142
LEASE DEPOSIT	61,467	77,544
INTANGIBLE ASSETS, NET	770,746	753,862
RIGHT OF USE ASSET	1,486,112	1,606,443
TOTAL ASSETS	7,556,918	8,542,000
CURRENT LIABILITIES
Accounts payable	892,700	634,564
Other current liabilities	171,493	238,554
Deferred revenue	10,310
Current portion of long-term debt
Current portion of lease liabilities	536,786	520,197
Total current liabilities	1,611,289	1,393,315
LONG-TERM LIABILITIES
Long-term portion of lease liabilities	1,042,745	1,183,872
Long term debt	9,219,420	8,111,610
Total long-term liabilities	10,262,165	9,295,482
TOTAL LIABILITIES	11,873,454	10,688,797
STOCKHOLDERS' EQUITY
Series A convertible preferred stock, 3,000,000 shares authorized, 1,890,354 shares issued and outstanding, liquidation value of $22,684,248 at March 31, 2020 and December 31, 2019	22,307,480	22,307,480
Common stock, no par value, 25,000,000 shares authorized, 4,024,443 shares issued and outstanding at March 31, 2020 and December 31, 2019	32,376,876	32,351,876
Additional paid-in capital	8,931,527	8,774,975
Accumulated deficit	(67,932,419)	(65,581,128)
Total stockholders' equity	(4,316,536)	(2,146,797)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 7,556,918	$ 8,542,000

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

XG SCIENCES INC 10-Q